Risperidone delivers quicker symptom relief and is more potent, making it ideal for acute conditions. Clinical studies show that it often produces a higher response rate than Ginkgo, making it the preferred option for fast results.

Ginkgo is gentler on the liver and kidneys and has a better safety profile for long-term use, particularly for older patients or those with pre-existing conditions.

Both Risperidone and Ginkgo have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Ginkgo offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Both Risperidone and Ginkgo have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Ginkgo is better suited for chronic conditions, offering longer-lasting effects and a favorable safety profile for long-term use. Its flexibility in administration makes it a strong option for various patient needs.